Denosumab causing severe, refractory hypocalcaemia in a patient with chronic kidney disease

BMJ Case Reports
Sameer SaleemNasir Saleem

Abstract

Denosumab is a fully human monoclonal antibody that is being increasingly used for the treatment of osteoporosis and prevention of skeletal-related events (SREs) in bone metastases from primary tumours. It has improved efficacy, better tolerability and convenient administration via subcutaneous route, in comparison with bisphosphonates; however, it has been reported to cause severe hypocalcaemia in certain high-risk individuals. We report the case of a 71-year-old man with a history of haemodialysis-dependent end-stage renal disease who developed severe hypocalcaemia with electrocardiographic changes after being started on denosumab for prevention of SREs from a recently diagnosed metastatic prostate cancer. He was admitted to the hospital for close monitoring and received multiple doses of intravenous calcium gluconate, along with haemodialysis with high calcium bath. We aim to highlight the risk of severe, life-threatening hypocalcaemia associated with denosumab and to recognise patients at risk of developing this serious adverse effect, so that prompt treatment and preventive strategies can be implemented.

References

Nov 1, 1982·Pacing and Clinical Electrophysiology : PACE·B StrasbergK Rosen
May 29, 2004·Clinical EEG and Neuroscience·C ArmelisassoS Mazza
Aug 5, 2005·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Stephen R BenoitDavid J Graham
Dec 17, 2005·Trends in Molecular Medicine·Teiji WadaJosef M Penninger
Feb 16, 2006·Drug Discovery Today·Mohammad A TabriziLorin K Roskos
Nov 20, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Paul J KostenuikJohn K Sullivan
Apr 26, 2012·Biologics : Targets & Therapy·Ursa Brown-Glaberman, Alison T Stopeck
Aug 3, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Brendan B McCormickKevin D Burns
May 11, 2013·BMJ : British Medical Journal·Fadil M Hannan, Rajesh V Thakker
Mar 21, 2015·American Journal of Nephrology·Vatsa DavePeter F Mount
Mar 26, 2016·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Pilar Monge RafaelGema Fernández-Fresnedo

❮ Previous
Next ❯

Citations

Mar 20, 2021·Health Technology Assessment : HTA·Danielle E RobinsonDaniel Prieto-Alhambra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Pierre Major
Case Reports in Nephrology
Mohammed Muqeet AdnanSyed Amer
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Maria A Lopez-OlivoMaria E Suarez-Almazor
© 2022 Meta ULC. All rights reserved